{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T17:40:08Z","timestamp":1748972408370,"version":"3.41.0"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,6]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Although the relationship between <jats:italic toggle=\"yes\">NUDT15<\/jats:italic> and thiopurine-induced leukopenia has been proven in previous studies, no prominent factors explaining interindividual variations in its active metabolite, 6-thioguanine nucleotide (6-TGN), and clinical efficacy have been identified. In this study, the correlation between genotypes (thiopurine S-methyltransferase, <jats:italic toggle=\"yes\">NUDT15<\/jats:italic>, and <jats:italic toggle=\"yes\">ITPA<\/jats:italic> polymorphisms), 6-TGN concentrations, and clinical outcomes (efficacy and side effects) in patients with inflammatory bowel disease were investigated.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>In total, 160 patients with inflammatory bowel disease were included, and the 3 genotyped genes and 6-TGN levels were measured by high-performance liquid chromatography. Statistical analyses and calculations were performed to determine their relationships.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>\n                                 <jats:italic toggle=\"yes\">ITPA<\/jats:italic> genotypes and 6-TGN concentration were both associated with the clinical effectiveness of azathioprine (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.036 and <jats:italic toggle=\"yes\">P<\/jats:italic> = 4.6 \u00d7 10<jats:sup>\u22127<\/jats:sup>), with a significant correlation also detected between them (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.042). Patients with <jats:italic toggle=\"yes\">ITPA<\/jats:italic> variant alleles exhibited higher 6-TGN levels than those with the wild-type allele. In addition, the relationship between <jats:italic toggle=\"yes\">NUDT15<\/jats:italic> and leukopenia and neutropenia was confirmed (<jats:italic toggle=\"yes\">P<\/jats:italic> = 1.79 \u00d7 10<jats:sup>\u22127<\/jats:sup> and 0.002).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>In summary, it is recommended that both <jats:italic toggle=\"yes\">ITPA<\/jats:italic> and <jats:italic toggle=\"yes\">NUDT15<\/jats:italic> genotyping should be performed before azathioprine initiation. Moreover, the 6-TGN concentration should be routinely monitored during the later period of treatment.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/ftd.0000000000000965","type":"journal-article","created":{"date-parts":[[2022,1,24]],"date-time":"2022-01-24T06:00:25Z","timestamp":1643004025000},"page":"391-395","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Inosine Triphosphate Pyrophosphatase and NUDT15 are Good Predictors of Clinical Outcomes in Thiopurine-Treated Chinese Patients with Inflammatory Bowel Disease"],"prefix":"10.1097","volume":"44","author":[{"given":"Xuemei","family":"Luo","sequence":"first","affiliation":[{"name":"Department of Medication, The Affiliated Drum Tower Hospital of Nanjing University Medical School; and"},{"name":"Nanjing Medical Center for Clinical Pharmacy, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simin","family":"Yan","sequence":"additional","affiliation":[{"name":"Department of Medication, The Affiliated Drum Tower Hospital of Nanjing University Medical School; and"},{"name":"Nanjing Medical Center for Clinical Pharmacy, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu","family":"Jin","sequence":"additional","affiliation":[{"name":"Department of Medication, The Affiliated Drum Tower Hospital of Nanjing University Medical School; and"},{"name":"Nanjing Medical Center for Clinical Pharmacy, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huaijun","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Medication, The Affiliated Drum Tower Hospital of Nanjing University Medical School; and"},{"name":"Nanjing Medical Center for Clinical Pharmacy, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoqi","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Medication, The Affiliated Drum Tower Hospital of Nanjing University Medical School; and"},{"name":"Nanjing Medical Center for Clinical Pharmacy, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weihong","family":"Ge","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, Jiangsu, China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250603","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1007\/s00535-017-1416-0","article-title":"Pharmacogenetics of thiopurines for inflammatory bowel disease in East Asia: prospects for clinical application of NUDT15 genotyping","volume":"53","author":"Kakuta","year":"2018","journal-title":"J Gastroenterol."},{"key":"R2-20250603","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/ajg.2011.64","article-title":"Efficacy of immunosuppressive therapy for inflammatory bowel disease: a systematic review and meta-analysis","volume":"106","author":"Khan","year":"2011","journal-title":"Am J Gastroenterol."},{"key":"R3-20250603","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/00008571-200208000-00003","article-title":"Azathioprine therapy and adverse drug reactions in patients with inflammatory bowel disease: impact of thiopurine S-methyltransferase polymorphism","volume":"12","author":"Schwab","year":"2002","journal-title":"Pharmacogenetics"},{"key":"R4-20250603","doi-asserted-by":"crossref","first-page":"51","DOI":"10.2217\/bmm.14.97","article-title":"Getting the best out of thiopurine therapy: thiopurine S-methyltransferase and beyond","volume":"9","author":"Fong","year":"2015","journal-title":"Biomark Med."},{"key":"R5-20250603","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.3389\/fphar.2018.01107","article-title":"Revisiting the role of thiopurines in inflammatory bowel disease through pharmacogenomics and use of novel methods for therapeutic drug monitoring","volume":"9","author":"Lim","year":"2018","journal-title":"Front Pharmacol."},{"key":"R6-20250603","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1046\/j.1365-2036.2002.01353.x","article-title":"Thiopurine methyltransferase activity and the use of azathioprine in inflammatory bowel disease","volume":"16","author":"Ansari","year":"2002","journal-title":"Aliment Pharmacol Ther."},{"key":"R7-20250603","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1111\/j.1572-0241.2008.01848.x","article-title":"Thiopurine-induced myelotoxicity in patients with inflammatory bowel disease: a review","volume":"103","author":"Gisbert","year":"2008","journal-title":"Am J Gastroenterol."},{"key":"R8-20250603","doi-asserted-by":"crossref","first-page":"460","DOI":"10.3389\/fphar.2018.00460","article-title":"NUDT15 R139C variants increase the risk of azathioprine-induced leukopenia in Chinese autoimmune patients","volume":"9","author":"Fei","year":"2018","journal-title":"Front Pharmacol."},{"key":"R9-20250603","first-page":"2062","article-title":"Study on the relationship between genetic polymorphism of TPMT and ITPA with adverse drug reactions in 6-mercaptopurine treatment","volume":"30","author":"Wei","year":"2010","journal-title":"Chin J Hosp Pharm."},{"key":"R10-20250603","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s00535-015-1142-4","article-title":"NUDT15 R139C-related thiopurine leukocytopenia is mediated by 6-thioguanine nucleotide-independent mechanism in Japanese patients with inflammatory bowel disease","volume":"51","author":"Asada","year":"2016","journal-title":"J Gastroenterol."},{"key":"R11-20250603","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s00535-008-2307-1","article-title":"Thioguanine S-methyltransferase and inosine triphosphate pyrophosphohydrolase genes in Japanese patients with inflammatory bowel disease in whom adverse drug reactions were induced by azathioprine\/6-mercaptopurine treatment","volume":"44","author":"Uchiyama","year":"2009","journal-title":"J Gastroenterol."},{"key":"R12-20250603","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1097\/FTD.0b013e3182731925","article-title":"Should thiopurine methyltransferase genotypes and phenotypes be measured before thiopurine therapy in patients with inflammatory bowel disease?","volume":"34","author":"Fangbin","year":"2012","journal-title":"Ther Drug Monit."},{"key":"R13-20250603","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s10038-004-0183-y","article-title":"Distribution of ITPA P32T alleles in multiple world populations","volume":"49","author":"Marsh","year":"2004","journal-title":"J Hum Genet."},{"key":"R14-20250603","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/bcpt.12958","article-title":"ITPA activity in children treated by azathioprine: relationship to the occurrence of adverse drug reactions and inflammatory response","volume":"122","author":"Citterio-Quentin","year":"2018","journal-title":"Basic Clin Pharmacol Toxicol."},{"key":"R15-20250603","doi-asserted-by":"crossref","first-page":"150.e1","DOI":"10.1016\/j.jpeds.2019.09.024","article-title":"The role of TPMT, ITPA, and NUDT15 variants during mercaptopurine treatment of Swedish pediatric patients with acute lymphoblastic leukemia","volume":"216","author":"Wahlund","year":"2020","journal-title":"J Pediatr."},{"key":"R16-20250603","first-page":"796","article-title":"Consensus on diagnosis and treatment of inflammatory bowel disease (Beijing, 2018)","volume":"38","year":"2018","journal-title":"Chin J Pract Intern Med."},{"issue":"suppl 2","key":"R17-20250603","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1046\/j.1365-2036.17.s2.17.x","article-title":"Review article: Crohn's disease: monitoring disease activity","volume":"17","author":"Sostegni","year":"2003","journal-title":"Aliment Pharmacol Ther."},{"key":"R18-20250603","doi-asserted-by":"crossref","first-page":"e0188925","DOI":"10.1371\/journal.pone.0188925","article-title":"Measurements of 6-thioguanine nucleotide levels with TPMT and NUDT15 genotyping in patients with Crohn's disease","volume":"12","author":"Lee","year":"2017","journal-title":"PLoS One"},{"key":"R19-20250603","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1093\/clinchem\/44.3.551","article-title":"Simultaneous determination of 6-thioguanine and methyl 6-mercaptopurine nucleotides of azathioprine in red blood cells by HPLC","volume":"44","author":"Dervieux","year":"1998","journal-title":"Clin Chem."},{"key":"R20-20250603","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1111\/apt.13796","article-title":"NUDT15 polymorphisms are better than thiopurine S-methyltransferase as predictor of risk for thiopurine-induced leukopenia in Chinese patients with Crohn's disease","volume":"44","author":"Zhu","year":"2016","journal-title":"Aliment Pharmacol Ther."},{"key":"R21-20250603","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1186\/1471-2407-14-299","article-title":"Prevalence of TPMT and ITPA gene polymorphisms and effect on mercaptopurine dosage in Chilean children with acute lymphoblastic leukemia","volume":"14","author":"Mauricio","year":"2014","journal-title":"BMC Cancer"},{"key":"R22-20250603","doi-asserted-by":"crossref","first-page":"7984","DOI":"10.1038\/s41598-021-87095-0","article-title":"Association of genetic variants in TPMT, ITPA, and NUDT15 with azathioprine-induced myelosuppression in southwest China patients with autoimmune hepatitis","volume":"11","author":"Miao","year":"2021","journal-title":"Sci Rep."},{"key":"R23-20250603","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1111\/j.1365-2036.2007.03278.x","article-title":"Thiopurine metabolite monitoring in paediatric inflammatory bowel disease","volume":"25","author":"Ooi","year":"2007","journal-title":"Aliment Pharmacol Ther."},{"key":"R24-20250603","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/00008571-200403000-00006","article-title":"Adverse drug reactions to azathioprine therapy are associated with polymorphism in the gene encoding inosine triphosphate pyrophosphatase (ITPase)","volume":"14","author":"Marinaki","year":"2004","journal-title":"Pharmacogenetics"},{"key":"R25-20250603","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1053\/gast.2002.32420","article-title":"6-MP metabolite profiles provide a biochemical explanation for 6-MP resistance in patients with inflammatory bowel disease","volume":"122","author":"Dubinsky","year":"2002","journal-title":"Gastroenterology"},{"key":"R26-20250603","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0016-5085(00)70140-5","article-title":"Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease","volume":"118","author":"Dubinsky","year":"2000","journal-title":"Gastroenterology"}],"container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0000000000000965","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T17:14:04Z","timestamp":1748970844000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0000000000000965"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/ftd.0000000000000965","relation":{},"ISSN":["0163-4356"],"issn-type":[{"type":"print","value":"0163-4356"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"2021-07-06","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-09-07","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}